Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee

NCT07550231 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis of the Knees

Interventions

DRUG: AD-211-L
DRUG: AD-211-M
DRUG: AD-211-H
DRUG: AD-2113
DRUG: Placebo to AD-211-L/M
DRUG: Placebo to AD-211-H
DRUG: Placebo to AD-2113

Sponsor

Addpharma Inc.